Catalyst
Slingshot members are tracking this event:
Phase 1/2 study testing ATB200 200-02 on Pompe disease data due third quarter of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| FOLD | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 04, 2017
Occurred Source:
http://ir.amicusrx.com/releasedetail.cfm?ReleaseID=1042705
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Pompe Disease, Atb200
